Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges that its officials will participate in an investor meeting arranged by Bank of America (BofA) on March 13, 2026, from 9:00 AM to 10:00 AM Singapore Time. The meeting will be an in-person group meeting held in Singapore. The company clarified that no unpublished price sensitive information (UPSI) will be discussed during the interaction, and the schedule is subject to change due to any exigencies on the part of the investor or the company.
This is a routine disclosure about management's participation in an investor conference with no material business announcement. It is unlikely to have any meaningful impact on the stock price, though it may offer institutional investors a chance to engage with the company on its strategy and outlook.